Biocompatible nano-micro-particles by solvent evaporation from multiple emulsions technique

Journal of Materials Science

Volumn 49, Issue 14, 2014, Pages 5160-5170

  Barba, Anna Angela ^a   Dalmoro, Annalisa ^a   D'Amore, Matteo ^a   Vascello, Clara ^a   Lamberti, Gaetano ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900459434     PISSN: 00222461     EISSN: 15734803     Source Type: Journal    
DOI: 10.1007/s10853-014-8224-1     Document Type: Article

References (52)

1. Xiong XY, Guo L, Gong YC et al (2012) In vitro & in vivo targeting behaviors of biotinylated pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction. Eur J Pharm Sci 46:537-544
2. Lee Y-S, Johnson PJ, Robbins PT, Bridson RH (2013) Production of nanoparticles-in-microparticles by a double emulsion method: a comprehensive study. Eur J Pharm Biopharm 83:168-173
3. KIlIçay E, Demirbilek M, Türk M, Güven E, Hazer B, Denkbas EB (2011) Preparation and characterization of poly(3-hydroxybutyrate-co- 3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy. Eur J Pharm Sci 44:310-320
4. Bernardi A, Zilberstein A, Jäger E et al (2009) Effects of indomethacin-loaded nanocapsules in experimental models of inflammtion in rats. Br J Pharmacol 158:1104-1111
5. Kim B-S, Kim C-S, Lee K-M (2008) The intracellular uptake ability of chitosan-coated poly(d,l-lactide-co-glycolide) nanoparticles. Arch Pharmacal Res 31:1050-1054
6. Steichen SD, Caldorera-Moore M, Peppas NA (2013) A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci 48:416-427
7. Torchilin VP (2007) Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 9:E128-E147
8. Spizzirri U, Iemma F, Altimari I, Curcio M, Puoci F, Picci N (2012) Grafted gelatin microspheres as potential pH-responsive devices. J Mater Sci 47:3648-3657. doi: 10.1007/s10853-011-6211-3
9. Béduneau A, Saulnier P, Benoit J-P (2007) Active targeting of brain tumors using nanocarriers. Biomaterials 28:4947-4967
10. Müller R, Jacobs C, Kayser O (2001) Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47:3-19
11. Carmen Varela M, Guzmán M, Molpeceres J, del Rosario Aberturas M, Rodriguez-Puyol D, Rodriguez-Puyol M (2001) Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats. Eur J Pharm Sci 12:471-478
12. Couvreur P, Vauthier C (2006) Nanotechnology: intelligent design to treat complex disease. Pharm Res 23:1417-1450
13. Fattal E, Barratt G (2009) Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA. Br J Pharmacol 157:179-194
14. Barba AA, Dalmoro A, d'Amore M, Lamberti G (2013) In vitro dissolution of pH sensitive micro-particles for colon-specific drug delivery. Pharm Dev Technol 18:1399-1406
15. Gaumet M, Vargas A, Gurny R, Delie F (2008) Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 69:1-9
16. Medina C, Santos-Martinez M, Radomski A, Corrigan O, Radomski M (2007) Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol 150:552-558
17. Keck CM, Müller RH (2013) Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems. Eur J Pharm Biopharm 84(3):445-448
18. Wang X, Wenk E, Hu X et al (2007) Silk coatings on PLGA and alginate microspheres for protein delivery. Biomaterials 28:4161-4169
19. Yang KK, Kong M, Wei YN et al (2013) Folate-modified - chitosan-coated liposomes for tumor-targeted drug delivery. J Mater Sci 48:1717-1728. doi: 10.1007/s10853-012-6930-0
20. ElBayoumi TA, Torchilin VP (2010) Current trends in liposome research. Methods Mol Biol 605:1-27
21. Bayindir ZS, Yuksel N (2010) Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 99:2049-2060
22. Svenson S (2009) Dendrimers as versatile platform in drug delivery applications. Eur J Pharm Biopharm 71:445-462
23. Letchford K, Burt H (2007) A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm 65:259-269
24. Dalmoro A, Lamberti G, Titomanlio G, Barba AA, d'Amore M (2010) Enteric micro-particles for targeted oral drug delivery. AAPS PharmSciTech 11:1500-1507
25. Kabanov AV, Vinogradov SV (2009) Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew Chem Int Ed 48:5418-5429
26. Benita S (2006) Microencapsulation: methods and industrial applications. Taylor & Francis, New York
27. Freitas S, Merkle H, Gander B (2005) Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release 102:313-332
28. Pérez E, Benito M, Teijón C, Olmo R, Teijón JM, Blanco MD (2012) Tamoxifen-loaded nanoparticles based on a novel mixture of biodegradable polyesters: characterization and in vitro evaluation as sustained release systems. J Microencapsul 29:309-322
29. Kompella UB, Bandi N, Ayalasomayajula SP (2003) Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol Vis Sci 44:1192-1201
30. Krishnamachari Y, Madan P, Lin S (2007) Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon. Int J Pharm 338:238-247
31. Lopes R, Eleutério CV, Gonçalves LMD, Cruz MEM, Almeida AJ (2012) Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. Eur J Pharm Sci 45:442-450
32. Song XR, Cai Z, Zheng Y et al (2009) Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. Eur J Pharm Sci 37:300-305
33. Sánchez A, Tobio M, González L, Fabra A, Alonso MJ (2003) Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. Eur J Pharm Sci 18:221-229
34. Bao T, Hiep N, Kim Y, Yang H, Lee B (2011) Fabrication and characterization of porous poly(lactic-co-glycolic acid) (PLGA) microspheres for use as a drug delivery system. J Mater Sci 46:2510-2517. doi: 10.1007/s10853-010-5101-4
35. Abismail B, Canselier JP, Wilhelm AM, Delmas H, Gourdon C (1999) Emulsification by ultrasound: drop size distribution and stability. Ultrason Sonochem 6:75-83
36. Gabor F (1999) Ketoprofen-poly(d,l-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. J Microencapsul 16:1-12
37. Yang Y, Chung T, Ng NP (2001) Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 22:231-241
38. Sipos P et al (2005) Influence of preparation conditions on the properties of eudragit microspheres produced by a double emulsion method. Drug Dev Res 64:41-54
39. Mainardes RM, Evangelista RC (2005) PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm 290:137-144
40. Behrend O, Ax K, Schubert H (2000) Influence of continuous phase viscosity on emulsification by ultrasound. Ultrason Sonochem 7:77-85
41. Li MK, Fogler HS (1978) Acoustic emulsification. Part 1. Form the initial droplets. J Fluid Mech 88:499-511
42. Li MK, Fogler HS (1978) Acoustic emulsiication. Part 2. Form the initial droplets. J Fluid Mech 88:513-528
43. Barba A, Dalmoro A, De Santis F, Lamberti G (2009) Synthesis and characterization of P(MMA-AA) copolymers for targeted oral drug delivery. Polym Bull 62:679-688
44. Joshi DP, Lan-Chun-Fung YL, Pritchard JG (1979) Determination of poly(vinyl alcohol) via its complex with boric acid and iodine. Anal Chim Acta 104:153-160
45. Barba AA, Chirico S, Dalmoro A, Lamberti G (2009) Simultaneous measurement of theophylline and cellulose acetate phthalate in phosphate buffer by UV analysis. Can J Anal Sci Spectros 53:249-253
46. Coulson J, Richardson J (1991) Chemical engineering. Volume 2: particle technology and separation processes. Pergamon Press, Oxford
47. Ye WP, Du FS, Jin WH, Yang JY, Xu Y (1997) In vitro degradation of poly(caprolactone), poly(lactide) and their block copolymers: influence of composition, temperature and morphology. React Funct Polym 32:161-168
48. Grayson ACR, Cima MJ, Langer R (2005) Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance. Biomaterials 26:2137-2145
49. Gonçalves CMB, Tomé LC, Coutinho JAP, Marrucho IM (2011) Addition of α-tocopherol on poly(lactic acid): thermal, mechanical, and sorption properties. J Appl Polym Sci 119:2468-2475
50. Huang MH, Li S, Hutmacher DW, Coudane J, Vert M (2006) Degradation characteristics of poly(?-caprolactone)-based copolymers and blends. J Appl Polym Sci 102:1681-1687
51. Ertl P (2008) Molecular drug properties. Wiley-VCH Verlag GmbH & Co, KGaA, Weinheim
52. Lee B, Rihards FM (1971) The interpretation of protein structures: estimation of static accessibility. J Mol Biol 55:379-400